BUSINESS OPPORTUNITIES

An integral part of our business strategy is to contribute our proprietary technology with full commitment to strenghten the core competencies of our partners. Our track record proves the success of our integrated concept. Since our platform technology is based on a modular and scalable concept it allows entry points at several project stages from early discovery to clinical phases available for partnering.

For our pipeline in the field of kinase and cytokine mediated anti inflammatiory products with significant commercial potential we seek experienced partners for outlicenising or early and late co-development.

Please contact licensing(at)origenis.com